{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:22:04Z","timestamp":1791332524211,"version":"4.3.1"},"reference-count":25,"publisher":"American Diabetes Association","issue":"6","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,6,1]]},"abstract":"<jats:p>Berardinelli-Seip congenital lipodystrophy (BSCL) is a heterogeneous genetic disease characterized by near absence of adipose tissue and severe insulin resistance. We have previously identified mutations in the seipin gene in a subset of our patients\u2019 cohort. Recently, disease-causing mutations in AGPAT2 have been reported in BSCL patients. In this study, we have performed mutation screening in AGPAT2 and the related AGPAT1 in patients with BSCL or other forms of lipodystrophy who have no detectable mutation in the seipin gene. We found 38 BSCL patients from 30 families with mutations in AGPAT2. Three of the known mutations were frequently found in our families. Of the eight new alterations, six are null mutations and two are missense mutations (Glu172Lys and Ala238Gly). All the patients harboring AGPAT2 mutations presented with typical features of BSCL. We did not find mutations in patients with other forms of lipodystrophies, including the syndromes of Lawrence, Dunnigan, and Barraquer-Simons, or with type A insulin resistance. In conclusion, mutations in the seipin gene and AGPAT2 are confined to the BSCL phenotype. Because we found mutations in 92 of the 94 BSCL patients studied, the seipin gene and AGPAT2 are the two major genes involved in the etiology of BSCL.<\/jats:p>","DOI":"10.2337\/diabetes.52.6.1573","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"1573-1578","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":79,"title":["Prevalence of Mutations in <i>AGPAT2<\/i> Among Human Lipodystrophies"],"prefix":"10.2337","volume":"52","author":[{"given":"Jocelyne","family":"Magre\u0301","sequence":"first","affiliation":[{"name":"INSERM U.402, Saint-Antoine Faculty of Medicine, University of Pierre and Marie Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Dele\u0301pine","sequence":"additional","affiliation":[{"name":"National Center of Genotyping, Evry, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Van Maldergem","sequence":"additional","affiliation":[{"name":"Center of Human Genetics, Institute of Pathology and Genetics, Loverval, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Robert","sequence":"additional","affiliation":[{"name":"Department of Pediatric Diabetology, Necker Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Antonie","family":"Maassen","sequence":"additional","affiliation":[{"name":"Sylvius Laboratory, University of Leiden Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Meier","sequence":"additional","affiliation":[{"name":"INSERM U.402, Saint-Antoine Faculty of Medicine, University of Pierre and Marie Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa R.","family":"Panz","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Ae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, da Crianca Institute, University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Tubiana-Rufi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Robert Debre\u0301 Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Czernichow","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Robert Debre\u0301 Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Seemanova","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Buchanan","sequence":"additional","affiliation":[{"name":"Department of Child Health, King\u2019s College Hospital, London, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Lacombe","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Pellegrin-Enfants Hospital, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[{"name":"INSERM U.402, Saint-Antoine Faculty of Medicine, University of Pierre and Marie Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lascols","sequence":"additional","affiliation":[{"name":"INSERM U.402, Saint-Antoine Faculty of Medicine, University of Pierre and Marie Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ronald","family":"Kahn","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Capeau","sequence":"additional","affiliation":[{"name":"INSERM U.402, Saint-Antoine Faculty of Medicine, University of Pierre and Marie Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lathrop","sequence":"additional","affiliation":[{"name":"National Center of Genotyping, Evry, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031209301801600_R1","doi-asserted-by":"crossref","unstructured":"Seip M, Trygstad O: Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl\u2008413:2\u201328,1996","DOI":"10.1111\/j.1651-2227.1996.tb14262.x"},{"key":"2022031209301801600_R2","doi-asserted-by":"crossref","unstructured":"Reitman ML, Arioglu E, Gavrilova O, Taylor SI: Lipoatrophy revisited. Trends Endocrinol Metab\u200811:410\u2013416,2000","DOI":"10.1016\/S1043-2760(00)00309-X"},{"key":"2022031209301801600_R3","doi-asserted-by":"crossref","unstructured":"Garg A: Lipodystrophies. Am J Med\u2008108:143\u2013152,2000","DOI":"10.1016\/S0002-9343(99)00414-3"},{"key":"2022031209301801600_R4","doi-asserted-by":"crossref","unstructured":"Bhayana S, Hegele RA: The molecular basis of genetic lipodystrophies. Clin Biochem\u200835:171\u2013177,2002","DOI":"10.1016\/S0009-9120(02)00297-7"},{"key":"2022031209301801600_R5","doi-asserted-by":"crossref","unstructured":"Lawrence RD: Lipodystrophy and hepatomegaly with diabetes, lipemia and other metabolic disturbances. Lancet\u20081:724\u2013741,1946","DOI":"10.1016\/S0140-6736(46)90528-4"},{"key":"2022031209301801600_R6","doi-asserted-by":"crossref","unstructured":"Magre\u0301 J, Dele\u0301pine M, Khallouf E, Gedde-Dahl T Jr, Van Maldergem L, Sobel E, Papp J, Meier M, Me\u0301garbane\u0301 A, Bachy A, Verloes A, d\u2019Abronzo FH, Seemanova E, Assan R, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F, de Kerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F, Navarro J, Nivelon-Chevalier A, Polak M, Robert JJ, Tric P, Tubiana-Rufi N, Vigouroux C, Weissenbach J, Savasta S, Maassen JA, Trygstad O, Bogalho P, Freitas P, Medina JL, Bonnicci F, Joffe BI, Loyson G, Panz VR, Raal FJ, O\u2019Rahilly S, Stephenson T, Kahn CR, Lathrop M, Capeau J: Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet\u200828:365\u2013370,2001","DOI":"10.1038\/ng585"},{"key":"2022031209301801600_R7","doi-asserted-by":"crossref","unstructured":"Agarwal AK, Arioglu E, De Almeida S, Akkoc N, Taylor SI, Bowcock AM, Barnes RI, Garg A: AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet\u200831:21\u201323,2002","DOI":"10.1038\/ng880"},{"key":"2022031209301801600_R8","doi-asserted-by":"crossref","unstructured":"Heathcote K, Rajab A, Magre\u0301 J, Syrris P, Besti M, Patton M, Dele\u0301pine M, Lathrop M, Capeau J, Jeffery S: Molecular analysis of Berardinelli-Seip congenital lipodystrophy in Oman: evidence for multiple loci. Diabetes\u200851:1291\u20131293,2002","DOI":"10.2337\/diabetes.51.4.1291"},{"key":"2022031209301801600_R9","doi-asserted-by":"crossref","unstructured":"Van Maldergem L, Magre\u0301 J, Gedde-DahlJr T, Khallouf E, Dele\u0301pine M, Trygstad O, Seemova E, Stephenson T, Albott C, Bonnici F, Panz V, Medina J-L, Bogalho P, Huet F, Savasta S, Verloes A, Robert J-J, Loret H, de Kerdanet M, Me\u0301garbane\u0301 A, Tubiana-Rufi N, Maassen A, Polak M, Lacombe D, Kahn C, Silveira E, d\u2019Abronzo H, Grigorescu F, Lathrop M, Capeau J, O\u2019Rahilly S: Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet\u200839:722\u2013733,2002","DOI":"10.1136\/jmg.39.10.722"},{"key":"2022031209301801600_R10","doi-asserted-by":"crossref","unstructured":"Bhayana S, Siu VM, Joubert GI, Clarson CL, Cao H, Hegele RA: Cardiomyopathy in congenital complete lipodystrophy. Clin Genet\u200861:283\u2013287,2002","DOI":"10.1034\/j.1399-0004.2002.610407.x"},{"key":"2022031209301801600_R11","doi-asserted-by":"crossref","unstructured":"Eberhardt C, Gray PW, Tjoelker LW: Human lysophosphatidic acid acyltransferase: cDNA cloning, expression, and localization to chromosome 9q34.3. J Biol Chem\u2008272:20299\u201320305,1997","DOI":"10.1074\/jbc.272.32.20299"},{"key":"2022031209301801600_R12","doi-asserted-by":"crossref","unstructured":"Eberhardt C, Gray PW, Tjoelker LW: cDNA cloning, expression and chromosomal localization of two human lysophosphatidic acid acyltransferases. Adv Exp Med Biol\u2008469:351\u2013356,1999","DOI":"10.1007\/978-1-4615-4793-8_51"},{"key":"2022031209301801600_R13","doi-asserted-by":"crossref","unstructured":"Leung DW: The structure and functions of human lysophosphatidic acid acyltransferases. Front Biosci\u20086:D944\u2013D953,2001","DOI":"10.2741\/A656"},{"key":"2022031209301801600_R14","unstructured":"Strachan T, Read AP: In Human Molecular Genetics. Oxford, U.K., BIOS Scientific Publishers Ltd,1996"},{"key":"2022031209301801600_R15","doi-asserted-by":"crossref","unstructured":"Kawaji H, Schonbach C, Matsuo Y, Kawai J, Okazaki Y, Hayashizaki Y, Matsuda H: Exploration of novel motifs derived from mouse cDNA sequences. Genome Res\u200812:367\u2013378,2002","DOI":"10.1101\/gr.193702"},{"key":"2022031209301801600_R16","doi-asserted-by":"crossref","unstructured":"Lewin TM, Wang P, Coleman RA: Analysis of amino acid motifs diagnostic for the sn-glycerol-3-phosphate acyltransferase reaction. Biochemistry\u200838:5764\u20135771,1999","DOI":"10.1021\/bi982805d"},{"key":"2022031209301801600_R17","doi-asserted-by":"crossref","unstructured":"Ruan H, Pownall HJ: Overexpression of 1-acyl-glycerol-3-phosphate acyltransferase-\u03b1 enhances lipid storage in cellular models of adipose tissue and skeletal muscle. Diabetes\u200850:233\u2013240,2001","DOI":"10.2337\/diabetes.50.2.233"},{"key":"2022031209301801600_R18","doi-asserted-by":"crossref","unstructured":"Hu\u0308bler A, Abendroth K, Keiner T, Stocker W, Kauf E, Hein G, Stein G: Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes. Exp Clin Endocrinol Diabetes\u2008106:79\u201384,1998","DOI":"10.1055\/s-0029-1211955"},{"key":"2022031209301801600_R19","doi-asserted-by":"crossref","unstructured":"Desbois-Mouthon C, Magre\u0301 J, Amselem S, Reynet C, Blivet MJ, Goossens M, Capeau J, Besmond C: Lipoatrophic diabetes: genetic exclusion of the insulin receptor gene. J Clin Endocrinol Metab\u200880:314\u2013319,1995","DOI":"10.1210\/jcem.80.1.7829633"},{"key":"2022031209301801600_R20","doi-asserted-by":"crossref","unstructured":"Panz VR, Raal FJ, O\u2019Rahilly S, Kedda MA, Joffe BI: Insulin receptor substrate-1 gene variants in lipoatrophic diabetes mellitus and non-insulin-dependent diabetes mellitus: a study of South African black and white subjects. Hum Genet\u2008101:118\u2013119,1997","DOI":"10.1007\/s004390050598"},{"key":"2022031209301801600_R21","doi-asserted-by":"crossref","unstructured":"Okazawa H, Mori H, Tamori Y, Araki S, Niki T, Masugi J, Kawanishi M, Kubota T, Shinoda H, Kasuga M: No coding mutations are detected in the peroxisome proliferator\u2013activated receptor-\u03b3 gene in Japanese patients with lipoatrophic diabetes. Diabetes\u200846:1904\u20131906,1997","DOI":"10.2337\/diab.46.11.1904"},{"key":"2022031209301801600_R22","doi-asserted-by":"crossref","unstructured":"Vigouroux C, Magre\u0301 J, Vantyghem MC, Bourut C, Lascols O, Shackleton S, Lloyd DJ, Guerci B, Padova G, Valensi P, Grimaldi A, Piquemal R, Touraine P, Trembath RC, Capeau J: Lamin A\/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes\u200849:1958\u20131962,2000","DOI":"10.2337\/diabetes.49.11.1958"},{"key":"2022031209301801600_R23","doi-asserted-by":"crossref","unstructured":"Vigouroux C, Khallouf E, Bourut C, Robert JJ, de Kerdanet M, Tubiana-Rufi N, Faure S, Weissenbach J, Capeau J, Magre\u0301 J: Genetic exclusion of 14 candidate genes in lipoatropic diabetes using linkage analysis in 10 consanguineous families. J Clin Endocrinol Metab\u200882:3438\u20133444,1997","DOI":"10.1210\/jc.82.10.3438"},{"key":"2022031209301801600_R24","doi-asserted-by":"crossref","unstructured":"Vigouroux C, Fajas L, Khallouf E, Meier M, Gyapay G, Lascols O, Auwerx J, Weissenbach J, Capeau J, Magre\u0301 J: Human peroxisome proliferator-activated receptor-\u03b32: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes. Diabetes\u200847:490\u2013492,1998","DOI":"10.2337\/diabetes.47.3.490"},{"key":"2022031209301801600_R25","doi-asserted-by":"crossref","unstructured":"Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J: The syndromes of insulin resistance and acanthosis nigricans: insulin-receptor disorders in man. N Engl J Med\u2008294:739\u2013745,1976","DOI":"10.1056\/NEJM197604012941401"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/52\/6\/1573\/374466\/db0603001573.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/52\/6\/1573\/374466\/db0603001573.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:18:15Z","timestamp":1667405895000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/52\/6\/1573\/14061\/Prevalence-of-Mutations-in-AGPAT2-Among-Human"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,1]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.52.6.1573","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,1]]}}}